Patrick M Schlievert Selected Research

Enterotoxins (Enterotoxin)

12/2019	High Prevalence of Staphylococcus aureus Enterotoxin Gene Cluster Superantigens in Cystic Fibrosis Clinical Isolates.
1/2019	Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
9/2017	The Staphylococcus aureus superantigen SElX is a bifunctional toxin that inhibits neutrophil function.
11/2016	Temporal and Racial Differences Associated with Atopic Dermatitis Staphylococcusaureus and Encoded Virulence Factors.
1/2016	Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis.
12/2014	Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers.
6/2014	Vaccination against Staphylococcus aureus pneumonia.
7/2011	Brucella sp. vertebral osteomyelitis with intercurrent fatal Staphylococcus aureus toxigenic enteritis in a bottlenose dolphin (Tursiops truncatus).
1/2010	Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis.
3/2009	Extreme pyrexia and rapid death due to Staphylococcus aureus infection: analysis of 2 cases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick M Schlievert Research Topics

Disease

44	Septic Shock (Toxic Shock Syndrome) 01/2022 - 02/2002
31	Infections 01/2021 - 05/2003
18	Endocarditis 01/2020 - 04/2002
8	Atopic Dermatitis (Atopic Eczema) 12/2019 - 01/2007
7	Inflammation (Inflammations) 01/2021 - 12/2008
7	Sepsis (Septicemia) 04/2020 - 04/2005
6	Fever (Fevers) 04/2020 - 06/2007
4	Purpura Fulminans 01/2021 - 04/2005
4	Pneumonia (Pneumonitis) 01/2021 - 09/2009
4	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021 - 06/2002
3	Necrotizing Pneumonia 09/2017 - 12/2010
3	Staphylococcal Pneumonia 01/2014 - 01/2007
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 12/2019
2	Kaposi Varicelliform Eruption (Eczema Herpeticum) 01/2021 - 01/2011
2	Exfoliative Dermatitis (Erythroderma) 04/2020 - 10/2011
2	Hypotension (Low Blood Pressure) 04/2020 - 12/2011
2	Lung Diseases (Lung Disease) 01/2016 - 12/2010
2	Hemolysis 12/2015 - 12/2007
2	Insulin Resistance 02/2015 - 01/2013
2	Osteomyelitis 01/2015 - 07/2011
2	Urinary Tract Infections (Urinary Tract Infection) 01/2015 - 05/2013
2	Ulcer 12/2014 - 01/2013
2	Staphylococcal Infections 07/2012 - 05/2008
2	Disseminated Intravascular Coagulation 01/2006 - 04/2005
2	Rheumatic Fever (Acute Articular Rheumatism) 01/2004 - 12/2002
2	Foodborne Diseases 05/2003 - 11/2002
1	Bullous Pemphigoid (Pemphigoid) 01/2022
1	Intractable Pain 04/2020
1	Erythema 04/2020
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 04/2020
1	Hypesthesia (Numbness) 04/2020
1	Job Syndrome (Hyper-IgE Syndrome) 04/2020
1	Cyanosis 04/2020
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Asymptomatic Infections 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	HIV Infections (HIV Infection) 11/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2017
1	Transfusion Reaction 05/2017
1	Stroke (Strokes) 01/2016
1	Wounds and Injuries (Trauma) 08/2015
1	Surgical Wound Infection 08/2015
1	Type 2 Diabetes Mellitus (MODY) 02/2015
1	Glucose Intolerance 02/2015
1	Foreign Bodies (Foreign Body) 01/2015
1	Diabetic Foot 12/2014

Drug/Important Bio-Agent (IBA)

39	SuperantigensIBA 01/2021 - 06/2002
18	Staphylococcal enterotoxin FIBA 01/2021 - 03/2003
18	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 02/2002
16	Enterotoxins (Enterotoxin)IBA 12/2019 - 11/2002
11	ExotoxinsIBA 01/2019 - 10/2004
9	CytokinesIBA 01/2013 - 11/2003
8	Proteins (Proteins, Gene)FDA Link 12/2019 - 05/2003
7	Cytotoxins (Cytolysins)IBA 12/2019 - 09/2009
5	Interleukin-8 (Interleukin 8)IBA 10/2020 - 12/2008
4	ChemokinesIBA 01/2021 - 04/2009
4	Anti-Infective Agents (Microbicides)IBA 01/2020 - 04/2009
3	AntibodiesIBA 01/2022 - 04/2002
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 05/2010
3	staphylococcal enterotoxin CIBA 01/2021 - 05/2008
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2020 - 11/2003
3	FibrinIBA 01/2017 - 04/2002
3	Peptide Hydrolases (Proteases)FDA Link 05/2013 - 08/2011
3	staphylococcal enterotoxin BIBA 01/2010 - 11/2003
3	Biological ProductsIBA 12/2007 - 11/2002
2	Glycoproteins (Glycoprotein)IBA 09/2016 - 07/2008
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2016 - 04/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 04/2002
2	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2016 - 12/2007
2	EndotoxinsIBA 02/2015 - 01/2013
2	monolaurinIBA 11/2013 - 04/2009
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 07/2008
2	Methicillin (Metin)FDA Link 01/2010 - 04/2005
2	Staphylococcus aureus RNAIIIIBA 04/2004 - 02/2002
2	EmeticsIBA 05/2003 - 11/2002
1	Immunoglobulin E (IgE)IBA 04/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	ElementsIBA 01/2020
1	DisulfidesIBA 01/2020
1	Mupirocin (Bactroban)FDA LinkGeneric 01/2020
1	Ointments (Pastes)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 11/2018
1	Serine Proteases (Serine Protease)IBA 09/2016
1	CA-125 Antigen (CA 125 Antigen)IBA 09/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016
1	Ligases (Synthetase)IBA 01/2016
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	Vancomycin FDA LinkGeneric 01/2016
1	LipopolysaccharidesIBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 02/2015
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015
1	Stainless Steel (Steel, Stainless)IBA 01/2015
1	Staphylococcal enterotoxin DIBA 12/2014
1	ToxoidsIBA 06/2014

Therapy/Procedure

6	Therapeutics 01/2016 - 01/2006
2	Catheters 01/2015 - 05/2013
1	Central Venous Catheters 05/2017
1	Operative Surgical Procedures 01/2016
1	Length of Stay 08/2015